# Design Therapeutics, Inc. (DSGN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/DSGN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -17.64M | $ -16.43M | $ 2.73M | $ 218.05M |
| 2025 | $ 0 | $ -71.46M | $ -55.86M | $ 645.0K | $ 212.50M |
| 2024 | $ 0 | $ -52.12M | $ -45.66M | $ 2.33M | $ 242.10M |
| 2023 | $ 0 | $ -72.29M | $ -63.59M | $ 3.05M | $ 277.69M |
| 2022 | $ 0 | $ -70.72M | $ -58.35M | $ 3.69M | $ 327.31M |
| 2021 | $ 0 | $ -42.24M | $ -36.75M | $ 3.63M | $ 382.13M |
| 2020 | $ 0 | $ -10.55M | $ -11.14M | $ 0 | $ -11.32M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.06 |
| Current Ratio | 22.28 |

## Other views

- [Metrics](https://sponda.capital/en/DSGN.md)
- [Charts](https://sponda.capital/en/DSGN/charts.md)
- [Compare](https://sponda.capital/en/DSGN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.